Investment Research Partners’s MetLife MET Stock Holding History

Investment Research Partners’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$253K	Buy	+2,987	New	+$241K	0.09%	244

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Investment Research Partners's MET Position: Q2 2026 in Review

Investment Research Partners opened a new position in MetLife (MET) in Q2 2026: 2,987 shares worth $253K. The stake represents 0.09% of the portfolio and ranks #244 among its holdings.

1,095 funds tracked by Wall St. Rank hold MET as of Q2 2026.

Investment Research Partners held 2,987 shares of MetLife worth $253K as of Q2 2026.
MetLife was a new Investment Research Partners position in Q2 2026.
MetLife made up 0.09% of Investment Research Partners's portfolio in Q2 2026, its #244 holding.
1,095 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Investment Research Partners's 13F filing for Q2 2026, filed 4 Aug 2026.